certainty right from the start
Join the Certara community of leading experts and scientists in biosimulation, clinical pharmacology, regulatory science, AI/ML, and clinical data science as we explore what’s possible at the Certainty US Annual Conference. Together, we’ll exchange insights, best practices, and proven strategies to bring greater clarity and confidence to every stage of drug discovery and development.
Meet the Certainty US 2026 Keynote
David Fajgenbaum, MD, MBA, MSc. Co-Founder and President of Every Cure, Bestselling Author of “Chasing My Cure”, and a physician-scientist at the University of Pennsylvania.
See what awaits you at Certainty
Certainty US 2026 will showcase how you can reduce risk and achieve success from molecule to market, with certainty right from the start.
Based on attendee feedback, Certainty 2026 will feature more in-depth UGMs and Workshops on Pinnacle 21, QSP, Phoenix, Discovery, PK/PD, and PBPK. Choose the interactive sessions that best suit your interests over the 2-days:
Phoenix User Meeting
Phoenix users can explore how empirical PK/PD methods work alongside in silico approaches by attending Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, you’ll get an interactive look at new features, our roadmap, and AI’s expanding role in modeling and reporting.
QSP Summit
Attendees of the QSP Summit are also encouraged to attend Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, we will explore how QSP is transforming MIDD through computational modeling, AI integration, and mechanistic insights. Sessions will feature case studies across disease areas, and forward-looking discussions on regulatory adoption and the future of predictive modeling.
Discovery: Intelligent Lead Optimization with Chemaxon and D360
With the explosion of new modalities, informatics is expanding its scope as AI closes gaps between chemistry, safety, and efficacy. Join this track to explore how predictive modeling is reshaping compound design and enabling a clearer view downstream in drug discovery.
PBPK Modeling Workshop
Attendees of PBPK Modeling Workshop are also encouraged to attend Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, we’ll showcase how PBPK informs decisions for first-in-human dosing to formulation, drug–drug interactions, and special population optimization. Expert talks and case studies will offer practical insights to strengthen confidence in model-informed development.
Modeling and Simulation from Strategy to Approval
Learn how empirical PK/PD methods like NCA and popPK are complementing in silico approaches like PBPK and QSP to answer the most daunting challenges in development, from optimal first-in-human dosing to presenting clin pharm evidence effectively in your NDA or BLA. Attendees of the Phoenix User Meeting, QSP Summit, and PBPK Modeling Workshop are encouraged to attend this session on Day 1 of Certainty.
reserve your spot
This two-day event will be filled with exciting customer presentations, industry thought leaders, valuable training sessions, and big announcements from Certara about the future of our products and services.
For your convenience you can book your stay here.




















